Therapeutic Strategies for the Treatment of Sickle Cell Disease
Martin K. Safo(Virginia Commonwealth University), Osheiza Abdulmalik(Children's Hospital of Philadelphia), Donald J. Abraham(Virginia Commonwealth University), James C. Burnett(Children's Hospital of Philadelphia), Anfal S. Aljahdali(King Abdulaziz University)
Cited by 8
Related Papers
In vivo hematopoietic stem cell modification by mRNA delivery
|Science|2023|321
Hemoglobin as a receptor of drugs and peptides: x-ray studies of the stereochemistry of binding
|Journal of the American Chemical Society|1986|301
5‐hydroxymethyl‐2‐furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells<sup>†,‡</sup>
|British Journal of Haematology|2005|244
Sphingosine-1-phosphate promotes erythrocyte glycolysis and oxygen release for adaptation to high-altitude hypoxia
|Nature Communications|2016|212